JAK2 c.211_212delinsTG ;(p.A71C)

Variant ID: 9-5022198-GC-TG

NM_004972.3(JAK2):c.211_212delinsTG;(p.A71C)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Advances in targeted therapy for malignant lymphoma.

Signal Transduction And Targeted Therapy
Wang, Li L; Qin, Wei W; Huo, Yu-Jia YJ; Li, Xiao X; Shi, Qing Q; Rasko, John E J JEJ; Janin, Anne A; Zhao, Wei-Li WL
Publication Date: 2020-03-06

Variant appearance in text: JAK2: A71C
PubMed Link: 32296035
Variant Present in the following documents:
  • Main text
View BVdb publication page